1. Home
  2. TMDX vs PAR Comparison

TMDX vs PAR Comparison

Compare TMDX & PAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • PAR
  • Stock Information
  • Founded
  • TMDX 1998
  • PAR 1968
  • Country
  • TMDX United States
  • PAR United States
  • Employees
  • TMDX N/A
  • PAR N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PAR Office Equipment/Supplies/Services
  • Sector
  • TMDX Health Care
  • PAR Miscellaneous
  • Exchange
  • TMDX Nasdaq
  • PAR Nasdaq
  • Market Cap
  • TMDX 2.7B
  • PAR 2.8B
  • IPO Year
  • TMDX 2019
  • PAR N/A
  • Fundamental
  • Price
  • TMDX $62.72
  • PAR $81.16
  • Analyst Decision
  • TMDX Buy
  • PAR Strong Buy
  • Analyst Count
  • TMDX 11
  • PAR 8
  • Target Price
  • TMDX $116.10
  • PAR $79.25
  • AVG Volume (30 Days)
  • TMDX 1.9M
  • PAR 430.6K
  • Earning Date
  • TMDX 10-28-2024
  • PAR 11-08-2024
  • Dividend Yield
  • TMDX N/A
  • PAR N/A
  • EPS Growth
  • TMDX N/A
  • PAR N/A
  • EPS
  • TMDX 0.94
  • PAR N/A
  • Revenue
  • TMDX $401,090,000.00
  • PAR $453,986,000.00
  • Revenue This Year
  • TMDX $82.52
  • PAR N/A
  • Revenue Next Year
  • TMDX $25.91
  • PAR $17.85
  • P/E Ratio
  • TMDX $70.11
  • PAR N/A
  • Revenue Growth
  • TMDX 109.09
  • PAR 49.11
  • 52 Week Low
  • TMDX $60.80
  • PAR $37.74
  • 52 Week High
  • TMDX $177.37
  • PAR $82.24
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 31.44
  • PAR 67.13
  • Support Level
  • TMDX $60.80
  • PAR $75.59
  • Resistance Level
  • TMDX $66.44
  • PAR $79.26
  • Average True Range (ATR)
  • TMDX 4.10
  • PAR 2.17
  • MACD
  • TMDX 0.50
  • PAR -0.49
  • Stochastic Oscillator
  • TMDX 13.30
  • PAR 87.67

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About PAR PAR Technology Corporation

PAR Technology Corp together with its subsidiaries provides management technology solutions including software, hardware, and related services, integral to the point-of-sale infrastructure and task management, information gathering, assimilation, and communication services. It has two segments. The restaurant/ Retail segment provides point-of-sale and management technology solutions such as hardware, software, and integrated technical solutions to the restaurant and retail industries. The government segment provides intelligence, surveillance, and reconnaissance solutions and mission systems support. The company derives the majority of its revenues from the Restaurant/ Retail segment.

Share on Social Networks: